Moderna sues rival Pfizer for vax patent infringement
Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in ...
Read moreTag: BioNTech
Pfizer says COVID shot 100% effective in adolescents after 4 months
Pfizer and BioNTech said Monday their COVID-19 vaccine remained 100 percent effective in children 12 to 15 years old, four ...
Read more
Pfizer strikes global licensing deal for cheap COVID-19 pill
US pharmaceutical giant Pfizer on Tuesday announced a deal to make its prospective antiviral COVID-19 pill available more cheaply in ...
Read more
Pfizer, Moderna, BioNTech make $1,000 profit every second
WASHINGTON—Pfizer, BioNTech and Moderna are making combined profits of $65,000 every minute from their highly successful COVID-19 vaccines while the ...
Read more
Pfizer, BioNTech, Moderna making $1,000 profit every second: analysis
Pfizer, BioNTech, and Moderna are making combined profits of $65,000 every minute from their highly successful COVID-19 vaccines while the ...
Read more
Pfizer requests US emergency use for booster shots
Drugmakers Pfizer and BioNTech announced they have formally submitted a request asking US officials for emergency authorization of their COVID-19 ...
Read more
Pfizer requests US emergency authorization for Covid booster for adults
Drugmakers Pfizer and BioNTech announced Tuesday they have formally submitted a request asking US officials for emergency authorization of their ...
Read more
Amnesty demands two billion Covid jabs for poorer world
Covid vaccine manufacturers are putting profit before lives, Amnesty International said on Wednesday, as it demanded two billion doses for ...
Read more
Pharmaceutical firms rake in billions with COVID jabs
COVID vaccines have brought billions of dollars to the coffers of pharmaceutical companies. Germany's BioNTech, maker with partner Pfizer of ...
Read more
BioNTech produces 10 times more antibodies than Sinovac
People who received BioNTech’s coronavirus vaccine had ten times the amount of antibodies than those given China’s Sinovac, a Hong ...
Read more
Manila Standard website (manilastandard.net), launched in August 2002, extends the newspaper’s reach beyond its traditional readers and makes its brand of Philippine news and opinion available to a much wider and geographically diverse readership here and overseas.